Atlas Trials

Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer

Clinical trial NCT04110769 · UNKNOWN

Trial details

NCT number
NCT04110769
Sponsor
Asan Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Genetic ChangeChemotherapy EffectPancreatic Cancer
Start date
2019-07-17
Primary completion
2023-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.